1-7 of 7
Annemiek B. van Spriel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High frequency of inactivating tetraspanin C D37 mutations in diffuse large B-cell lymphoma at immune-privileged sites

Brief Report
Suraya Elfrink, Charlotte M. de Winde, Michiel van den Brand, Madeleine Berendsen, Margaretha G. M. Roemer, Frank Arnold, Luuk Janssen, Alie van der Schaaf, Erik Jansen, Patricia J. T. A. Groenen, Astrid Eijkelenboom, Wendy Stevens, Corine J. Hess, J. Han van Krieken, Joost S. P. Vermaat, Arjen H. G. Cleven, Ruben A. L. de Groen, Viviana Neviani, Daphne de Jong, Sjoerd van Deventer, Blanca Scheijen, Annemiek B. van Spriel
Journal: Blood
Blood (2019) 134 (12): 946–950.
https://doi.org/10.1182/blood.2019001185
Published: 2019
Includes: Supplemental data
Journal Articles

Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma

Clinical Trials & Observations
Zijun Y. Xu-Monette, Ling Li, John C. Byrd, Kausar J. Jabbar, Ganiraju C. Manyam, Charlotte Maria de Winde, Michiel van den Brand, Alexandar Tzankov, Carlo Visco, Jing Wang, Karen Dybkaer, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W. L. Choi, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Ben M. Parsons, Jane N. Winter, Michael Wang, Frederick B. Hagemeister, Miguel A. Piris, J. Han van Krieken, L. Jeffrey Medeiros, Yong Li, Annemiek B. van Spriel, Ken H. Young
Journal: Blood
Blood (2016) 128 (26): 3083–3100.
https://doi.org/10.1182/blood-2016-05-715094
Published: 2016
Includes: Supplemental data
Journal Articles

The Role of Tetraspanin CD37 in B-Cell Malignancy

Kyle A. Beckwith, BS, Erich I. Williams, BS, Mark D. Wright, PhD, Annemiek B. van Spriel, PhD, John C. Byrd, MD, Natarajan Muthusamy, DVM, PhD
Journal: Blood
Blood (2015) 126 (23): 1258.
https://doi.org/10.1182/blood.V126.23.1258.1258
Published: 2015
Journal Articles

Mac-1 (CD11b/CD18) is crucial for effective Fc receptor–mediated immunity to melanoma

Annemiek B. van Spriel, Heidi H. van Ojik, Annie Bakker, Marco J. H. Jansen, Jan G. J. van de Winkel
Journal: Blood
Blood (2003) 101 (1): 253–258.
https://doi.org/10.1182/blood.V101.1.253
Published: 2003
Journal Articles

Mac-1 (CD11b/CD18) is essential for Fc receptor–mediated neutrophil cytotoxicity and immunologic synapse formation

Annemiek B. van Spriel, Jeanette H. W. Leusen, Marjolein van Egmond, Henry B. P. M. Dijkman, Karel J. M. Assmann, Tanya N. Mayadas, Jan G. J. van de Winkel
Journal: Blood
Blood (2001) 97 (8): 2478–2486.
https://doi.org/10.1182/blood.V97.8.2478
Published: 2001
Journal Articles

Human Immunoglobulin A Receptor (FcRI, CD89) Function in Transgenic Mice Requires Both FcR γ Chain and CR3 (CD11b/CD18)

Marjolein van Egmond, A.J. Hanneke van Vuuren, H. Craig Morton, Annemiek B. van Spriel, Li Shen, Frans M.A. Hofhuis, Takashi Saito, Tanya N. Mayadas, J. Sjef Verbeek, Jan G.J. van de Winkel
Journal: Blood
Blood (1999) 93 (12): 4387–4394.
https://doi.org/10.1182/blood.V93.12.4387
Published: 1999
Journal Articles

FcαRI (CD89) as a Novel Trigger Molecule for Bispecific Antibody Therapy

Thomas Valerius, Bernhard Stockmeyer, Annemiek B. van Spriel, Robert F. Graziano, Ingrid E. van den Herik-Oudijk, Roland Repp, Yashwant M. Deo, John Lund, Joachim R. Kalden, Martin Gramatzki, Jan G.J. van de Winkel
Journal: Blood
Blood (1997) 90 (11): 4485–4492.
https://doi.org/10.1182/blood.V90.11.4485
Published: 1997